Delaware counts the cost of a Pfizer takeover of AstraZeneca

The state of Delaware is worried that it would lose AstraZeneca's ($AZN) U.S. headquarters--and the thousands of jobs that go with it--should Pfizer ($PFE) succeed in buying the U.K. company. Report

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.